Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 03-2013 | |
| Operating Expenses | 0 | 1,763 | 2,135 | 0 | 603 |
| Operating Income | N/A | -1,763 | -2,135 | N/A | -603 |
| Other Income | 0 | 6 | -26 | 0 | 1,210 |
| Pre-tax Income | 0 | -1,757 | -2,161 | 0 | 607 |
| Net Income Continuous | N/A | -1,757 | -2,161 | N/A | 607 |
| Net Income | $N/A | $-1,757 | $-2,161 | $N/A | $607 |
| EPS Basic Total Ops | N/A | -25.20 | -48.60 | N/A | 21.60 |
| EPS Basic Continuous Ops | N/A | -28.49 | -48.74 | N/A | 21.87 |
| EPS Diluted Total Ops | N/A | -25.20 | -48.60 | N/A | 21.60 |
| EPS Diluted Continuous Ops | N/A | -28.49 | -48.74 | N/A | 21.87 |
| EBITDA(a) | $N/A | $-1,763 | $-2,135 | $N/A | $-603 |